Skip to main content

United States News All stories

Every story in this section, newest first — page 341 of 373.

Grafa
Health

Oculis to showcase late-stage ophthalmology pipeline at 2026 J.P. Morgan healthcare conference

Oculis Holding AG (NASDAQ:OCS) is set to showcase its late-stage ophthalmology pipeline at the 44th Annual J.P. Morgan Healthcare Conference on January 14, following a pivotal start to the year.

Read more: Oculis to showcase late-stage ophthalmology pipeline at 2026 J.P. Morgan healthcare conference
Grafa
Advertising and Marketing

Super League acquires Let’s Bounce to enhance in-game brand engagement capabilities

Super League Enterprise (NASDAQ:SLE) announced on January 7, 2026, the acquisition of Let’s Bounce (Bounce), a marketing-technology company specializing in scalable brand engagement within gaming and user-generated content (UGC) environments.

Read more: Super League acquires Let’s Bounce to enhance in-game brand engagement capabilities
Grafa
Technology

CoStar Group projects record $800M profitability, authorizes $1.5B buyback

CoStar Group (NASDAQ:CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology in the property markets, today announced an update on its key business, financial, and corporate governance initiatives for 2026 and beyond.

Read more: CoStar Group projects record $800M profitability, authorizes $1.5B buyback
Grafa
Media

Warner Bros. Discovery board unanimously recommends rejection of Paramount-Skydance amended offer

Warner Bros. Discovery (NASDAQ:WBD) announced that its Board of Directors has unanimously recommended that shareholders reject the amended tender offer from Paramount Skydance (PSKY) and continue to support the pending merger with Netflix (NASDAQ:NFLX).

Read more: Warner Bros. Discovery board unanimously recommends rejection of Paramount-Skydance amended offer
Grafa
Health

Arrowhead Pharmaceuticals Secures Chinese Approval for REDEMPLO in Familial Chylomicronemia Syndrome

Arrowhead Pharmaceuticals (NASDAQ:ARWR) today announced that the Chinese National Medical Products Administration (NMPA) has approved REDEMPLO® (plozasiran) for the reduction of triglyceride levels in adult patients with familial chylomicronemia syndrome (FCS).

Read more: Arrowhead Pharmaceuticals Secures Chinese Approval for REDEMPLO in Familial Chylomicronemia Syndrome
Grafa

Albertsons digital growth surges 21% as grocer pivots following failed Kroger tie-up

Albertsons Companies (NYSE:ACI) today announced its financial results for the third quarter of fiscal 2025, ended November 29, 2025.

The company reported identical sales growth of 2.4%, with digital sales surging 21% year-over-year.

Read more: Albertsons digital growth surges 21% as grocer pivots following failed Kroger tie-up
Grafa
Technology

Netflix welcomes Warner Bros. Discovery board's reaffirmation of merger agreement

Netflix (NASDAQ:NFLX) issued a statement welcoming the Warner Bros. Discovery board's unanimous reaffirmation of their merger agreement and its strong recommendation that stockholders reject the revised offer from Paramount and Skydance.

Read more: Netflix welcomes Warner Bros. Discovery board's reaffirmation of merger agreement